MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CNTA has $641,763K in assets. $154,415K in debts. $62,431K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
953.35%
Quick Ratio
953.35%
Cash Ratio
170.70%
Debt to Asset Ratio
24.06%
Unit: Thousand (K) dollars
Assets Breakdown
    • Long-term investments
    • Short-term investments
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Long term debt
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
62,431 61,299 50,811 44,242
Short-term investments
214,158 233,281 195,403 206,482
Tax incentive receivable
56,431 53,917 49,121 40,704
Prepaid expenses and other current assets
15,659 19,378 12,340 8,935
Total current assets
348,679 367,875 307,675 300,363
Long-term investments
257,117 282,548 102,825 153,406
Property and equipment, net
722 807 894 733
Operating lease right-of-use assets
9,794 10,047 10,295 10,539
Deferred tax asset
24,171 24,778 25,022 25,366
Other non-current assets
1,280 1,440 1,589 1,720
Total assets
641,763 687,495 448,300 492,127
Accounts payable
10,658 7,582 8,683 5,692
Accrued expenses and other current liabilities
25,916 35,353 20,439 24,002
Total current liabilities
36,574 42,935 29,122 29,694
Long term debt
110,440 110,095 109,816 109,545
Operating lease liabilities
7,372 7,573 7,759 7,940
Other liabilities
29 29 29 29
Total liabilities
154,415 160,632 146,726 147,208
Ordinary shares 0.002 nominal value222,480,776shares authorized, 154,728,966 issued and outstanding at march31, 2026 222,480,776 shares authorized, 149,228,068 issued and outstanding at december31, 2025
419 405 364 363
Additional paid-in capital
1,750,996 1,709,978 1,418,681 1,408,145
Accumulated other comprehensive income
1,408 2,714 2,600 1,591
Accumulated deficit
-1,265,475 -1,186,234 -1,120,071 -1,065,180
Total shareholders equity
487,348 526,863 301,574 344,919
Total liabilities and shareholders' equity
641,763 687,495 448,300 492,127
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$214,158K (19.41%↑ Y/Y)Cash and cashequivalents$62,431K (-40.63%↓ Y/Y)Tax incentivereceivable$56,431K (13.75%↑ Y/Y)Prepaid expenses andother current assets$15,659K (15.10%↑ Y/Y)Total current assets$348,679K (0.28%↑ Y/Y)Long-term investments$257,117K (83.14%↑ Y/Y)Deferred tax asset$24,171K (-8.41%↓ Y/Y)Operating leaseright-of-use assets$9,794K (-9.13%↓ Y/Y)Other non-currentassets$1,280K (-31.99%↓ Y/Y)Property and equipment,net$722K (6.02%↑ Y/Y)Total assets$641,763K (21.58%↑ Y/Y)Total liabilities andshareholders' equity$641,763K (21.58%↑ Y/Y)Total shareholdersequity$487,348K (26.18%↑ Y/Y)Total liabilities$154,415K (9.05%↑ Y/Y)Accumulated deficit-$1,265,475K (-24.70%↓ Y/Y)Additional paid-in capital$1,750,996K (25.19%↑ Y/Y)Long term debt$110,440K (1.09%↑ Y/Y)Total currentliabilities$36,574K (51.12%↑ Y/Y)Operating leaseliabilities$7,372K (-9.16%↓ Y/Y)Other liabilities$29K (0.00%↑ Y/Y)Accumulated othercomprehensive income$1,408K (-32.14%↓ Y/Y)Ordinary shares 0.002nominal...$419K (15.75%↑ Y/Y)Accrued expenses andother current...$25,916K (35.90%↑ Y/Y)Accounts payable$10,658K (107.68%↑ Y/Y)

Centessa Pharmaceuticals plc (CNTA)

Centessa Pharmaceuticals plc (CNTA)